Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Rüdersdorf

15 clinical trials in Rüdersdorf, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Rüdersdorf at a glance
15
clinical trials
  • Paediatric trials0
  • Research sites1
Type of trial
Recruitment status
Quick filters

15 trials in Rüdersdorf

Open in trial search
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Efgartigimod Alfa
  • Sponsor:Janssen - Cilag International
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Pelacarsen
  • Sponsor:Novartis Pharma AG
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Dnth103
  • Sponsor:Dianthus Therapeutics Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Rozanolixizumab
  • Sponsor:UCB Biopharma

Ocular myasthenia

Not yet recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Rozanolixizumab
  • Sponsor:UCB Biopharma
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Beclometasone Dipropionate
  • Sponsor:Chiesi Farmaceutici S.p.A.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Sponsor:Amgen Inc.

Arteriosclerosis

Not recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Pelacarsen
  • Sponsor:Novartis Pharma AG

Arteriosclerosis+1

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Glucose Monohydrate
  • Sponsor:Novartis Pharma AG
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Stemline Therapeutics Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Nipocalimab
  • Sponsor:Janssen - Cilag International

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Rüdersdorf

What the registry says about research in the country

01 Cardiovascular Research

Research focusing on cardiovascular disease treatments and innovative therapies for reducing major cardiovascular events. Studies explore new approaches to managing hypercholesterolemia and lipid disorders.

  • Lipoprotein(a) reduction therapy
  • LDL cholesterol management
  • Cardiovascular risk prevention

Groundbreaking trials comparing different therapeutic approaches for patients with established cardiovascular conditions.

02 Oncology Studies

Advanced research in breast cancer treatment, specifically targeting node-positive, estrogen receptor-positive, HER2-negative early breast cancer cases.

  • Endocrine therapy comparison
  • Recurrence risk management
  • Gender-inclusive treatment approaches

Innovative trials evaluating novel therapeutic options for high-risk breast cancer patients.

03 Inflammatory Disorders

Comprehensive studies on various inflammatory conditions including dermatomyositis and inflammatory myopathies. Research encompasses both rare and complex muscular disorders.

  • Myositis treatment innovations
  • Novel therapeutic antibodies
  • Inflammatory disease management

Multiple trials exploring breakthrough treatments for patients with challenging inflammatory conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.